Address: PharmaPack International B.V., Bleiswijkseweg 51, NL-2712 PB ZOETERMEER, the Netherlands
Tel: 0031 (0)79 3465 999
Web: http://www.pharmapack.nl/
PharmaPack International specializes in packaging pharmaceutical as well as biotechnological products. We are experienced with the various product, organizational or country-specific packaging requirements, and are proud that many leading pharmaceutical companies constantly rely on our expertise and quality care.
Business premises Zoetermeer, the Netherlands.
You can rest assured that PharmaPack will package your products efficiently, responsibly and according to the highest quality standards. This is accomplished through deployment of the right combination of people, machines, quality systems and business partners. Furthermore, we have the necessary facilities for storage and distribution of bulk products. Five basic principles underlie our service provision: quality, choice, value, inspiration and innovation. We apply these principles for one purpose only; to ensure optimum customer satisfaction.
Market leader:
PharmaPack International has been involved in the pharmaceutical service industry for almost 30 years. In 1983 we started out as a pharmaceutical contract packager in Rijswijk, the Netherlands. Thanks to our efficient production process, good price-quality ratio and great delivery performance, we developed into one of the largest pharmaceutical packers in Europe as well as a market leader in the Netherlands.
In 1998 our successful growth necessitated a move to larger premises in Zoetermeer where we are able to provide optimum service in a well-equipped business environment. PharmaPack International has the know-how required to ensure the efficient and responsible packaging of your pharmaceutical as well as biotechnological products. We are pleased to take care of the entire packaging process on your behalf. We proudly take care of your packaging needs.
To enable this we utilize ten blister packaging lines, some of which are used exclusively for hospital packaging (EAV). In addition dedicated packaging lines for bottles and containers as well as manual packaging lines are employed. We also process de-blistering activities as well as repackaging orders in both large and small batches effectively.
Primary packaging:
Blisters, containers, EAV hospital packaging, buckets, bulk packaging, deblistering.
Secondary packaging:
Vials, inhalers, cartons, manual packaging, repackaging, inspection.
Purchase of packaging components.
Bulk sampling and quarantine storage.
Packaging and storage of opiates.
Storage and distribution (2 – 8 and 15 – 25 degrees)
Packaging of clinical trials.
Entire (cold) supply chain solutions.
PharmaPack’s Clinical Services
Packaging is an integral part of the (clinical) supply chain. Not only do we assist in finding optimal packaging solutions, moreover do we try to create a most flexible and efficient clinical supply chain. In our experiences every clinical project demands a unique approach, dedicated project team, and above all: thorough preparation.
PharmaPack’s clinical services include:
Project Management (randomization, blind and double blind)
Sourcing packaging materials
Packaging (i.e. blistering, labeling, kit preparation etc.)
Warehousing, Order Management & Distribution
While working in close collaboration with CRO’s we have managed several European as well as World Wide clinical projects. For more information regarding PharmaPack’s Clinical Services, please contact info@pharmapack.nl
The EMA’s Peter Arlett looks back on two years of the Accelerating Clinical Trials in the European Union (ACT EU) initiative which aims to improve the environment for clinical trials…
New methodology for the 2024 Access to Medicine Index promises a stronger attempt to quantify whether drugs, vaccines, and diagnostics are actually making it all the way to patients in…
Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to outline what more generics companies can be doing to…
As part of a wide-ranging conversation with PharmaBoardroom published earlier this month, European Medicines Agency (EMA) Executive Director Emer Cooke laid out four of the Agency’s core focus areas for…
In conversation at DIA Europe 2023 in Basel, European Medicines Agency Executive Director Emer Cooke looks back at the lessons EMA has taken from the COVID-19 pandemic response, outlines the…
The Access to Medicine Index, a biennial report that gauges the efforts of the world’s largest pharma companies to expand access in low- and middle-income countries (LMICs), found in this…
The latest news from the Dutch pharma, biotech and healthcare industries, including the bullish comments of Argenx CEO Tim Van Hauwermeiren following the successful launch of its Vyvgart product; cancer…
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use within the European Union, concluded a vote on Monday evening in Brussels following…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in the Netherlands, the resulting second pillar of specialty products for the…
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands nevertheless still sits in fourth position on the 2015…
The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the Dutch ambition to be a frontrunner in new healthcare challenges also comprises an…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease patients and their families. Karel Fol, the country manager…
See our Cookie Privacy Policy Here
